Juno vs Recursion
Side-by-side comparison of features, pricing, and ratings
At a glance
| Dimension | Juno | Recursion |
|---|---|---|
| Pricing | Freemium | Contact for pricing |
| Target Audience | Chronic illness patients (ME/CFS, fibromyalgia, autoimmune) | Pharma companies, biotech investors, researchers |
| Primary Data Type | User-reported symptoms, medications, sleep, activity, mood | Phenomics, transcriptomics, proteomics, ADME, patient data |
| Key Capability | Symptom tracking, pattern recognition, doctor-ready reports | Drug discovery and development platform |
| Integrations | None listed | NVIDIA, BioHive-2 supercomputer |
| Clinical Pipeline | Not applicable | REC-4881 (Phase 1b/2 positive), REC-3565 (Phase 1 dosed), others |
Recursion and Juno serve entirely different needs. Recursion is a high-investment platform for pharmaceutical companies aiming to accelerate drug discovery with massive datasets and wet-lab validation. Juno is a freemium, user-friendly app for individuals managing chronic illnesses to track symptoms and generate reports for doctors. If you're a patient, Juno is the clear choice; if you're a pharma R&D team, Recursion's custom partnership is the path forward.
AI-driven drug discovery platform using phenomics, massive datasets, and wet-lab automation
Visit WebsiteWhat real users say: Juno vs Recursion
Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.
Juno
63 mentions across 3 sources · 7% positive — critical
Hacker News, App Store, Lemmy
What users praise
- • Good community aspect for chronic illness support.
- • Allows tracking of symptoms, meds, sleep, and mood.
- • Helps some users organize health data for doctor visits.
- • Positive initial experience before hitting paywall.
What frustrates them
- • Unable to cancel subscription or delete account easily.
- • App crashes frequently, especially on iPhone 16 Pro.
- • Chat support doesn't work and robo-responses are useless.
- • Free tier runs out of credits almost immediately.
Researched Jul 3, 2026
Recursion
68 mentions across 4 sources · 45% positive — mixed
Reddit, Hacker News, Stack Overflow, Lemmy
What users praise
- • Massive dataset integration (50+ petabytes) for deep biological insights
- • Automated wet lab enables millions of experiments weekly, accelerating discovery
- • Strategic NVIDIA partnership provides cutting-edge compute power
- • Multiple clinical trials with early positive data validate approach
What frustrates them
- • Highly complex platform requires advanced technical expertise to use
- • Proprietary algorithms and data limit external validation and trust
- • Clinical success still unproven; most programs in early phases
- • High cost likely restricts access to well-funded organizations
Researched Jul 31, 2026
Feature-by-feature
Recursion and Juno are incomparable in function. Recursion offers a full-stack drug discovery platform integrating automated wet labs (robotics, computer vision), >50 petabytes of multi-omics data, and NVIDIA BioHive-2 supercomputing for AI model training. Its features include hit identification, target validation, generative molecule design, and de-identified patient data integration, with a clinical pipeline (e.g., REC-4881 in Phase 1b/2). Juno, in contrast, is a personal health app focusing on customizable symptom tags, pattern recognition, automated doctor-ready reports (PDF/CSV export), medication logging, sleep/activity tracking, mood diary, and reminders. Recursion requires deep partnerships and custom pricing; Juno is freemium for individual users. No feature overlap exists.
Pricing compared
Recursion's pricing is contact-based, meaning costs are negotiated per partnership – suited for large pharma or biotech with serious R&D budgets. Juno uses a freemium model, making it accessible to individual patients at no upfront cost, with likely premium tiers for advanced features (though not detailed). Recursion’s cost reflects enterprise infrastructure (supercomputing, automated labs) and clinical-stage assets. Juno’s freemium model targets affordability for chronic illness management. There is no direct price comparison; budget-friendly patients choose Juno, while corporate R&D budgets require Recursion.
Who should pick which
- Chronic illness patient (e.g., ME/CFS, fibromyalgia)Pick: Juno
Juno provides structured symptom tracking, pattern analysis, and doctor-ready report generation – exactly what patients need to communicate with specialists and reduce cognitive load.
- Pharmaceutical R&D teamPick: Recursion
Recursion offers AI-driven drug discovery with massive phenomics data, automated wet lab, and supercomputing – ideal for accelerating pipeline and reducing failure rates.
- Biotech investor evaluating AI drug platformsPick: Recursion
Recursion's clinical pipeline (REC-4881, REC-3565) and techbio approach with proprietary data and NVIDIA partnership make it a compelling investment target.
- Autoimmune disease patient needing symptom logs for doctor visitsPick: Juno
Juno's customizable tags and automated reports simplify tracking multiple conditions (lupus, arthritis) and produce PDF/CSV exports for medical appointments.
- Academic researcher in rare disease drug discoveryPick: Recursion
Recursion's platform enables target identification and molecule design using phenomics and patient data – but requires partnership pricing, unsuitable for low budgets.
Frequently Asked Questions
Juno vs Recursion: which should you choose?
Recursion and Juno serve entirely different needs. Recursion is a high-investment platform for pharmaceutical companies aiming to accelerate drug discovery with massive datasets and wet-lab validation. Juno is a freemium, user-friendly app for individuals managing chronic illnesses to track symptoms and generate reports for doctors. If you're a patient, Juno is the clear choice; if you're a pharma R&D team, Recursion's custom partnership is the path forward.
Can Juno help with mental health conditions?
Juno focuses on chronic physical illnesses (ME/CFS, fibromyalgia, autoimmune) but includes mood and energy tracking that could be useful for mental health conditions, though it's not its primary design.
Does Recursion offer a free trial or software subscription?
No – Recursion is not a standalone software product; it requires a custom partnership with custom pricing, not a trial or subscription.
Does Juno provide medical advice or diagnosis?
No – Juno is a tracking and reporting tool, not a diagnostic AI. It helps users document symptoms for healthcare providers but does not offer medical advice.
What data does Recursion use for drug discovery?
Recursion uses over 50 petabytes of phenomics, transcriptomics, proteomics, ADME, and de-identified patient data, processed via automated labs and NVIDIA BioHive-2.
Can I export my Juno data to share with a doctor?
Yes – Juno generates automated doctor-ready reports and supports data export in PDF and CSV formats.
Does Recursion have any FDA-approved drugs?
Recursion's pipeline is in clinical trials (e.g., REC-4881 Phase 1b/2 positive, REC-3565 Phase 1 dosed); no approved drugs are mentioned.
Is Juno suitable for cancer patients?
Juno supports multi-condition tracking, so it could be used for symptom management during cancer treatment, though it's marketed toward ME/CFS, fibromyalgia, and autoimmune.
More Juno or Recursion comparisons
If you're a patient managing a chronic condition, Juno gives you a freemium AI companion to log symptoms and generate doctor-ready reports. If you're a pharma company needing to accelerate drug discov
CodaMetrix and Juno serve completely different needs. For large health systems seeking to cut coding costs and denials, CodaMetrix's enterprise AI with deep EHR integration and 5:1 ROI is unmatched —
RapidSOS is essential for public safety agencies and enterprises needing real-time emergency intelligence, but is overkill for individuals. Juno is purpose-built for chronic illness patients tracking
If you're a pharma company aiming to slash drug failure rates, Recursion's integrated platform and clinical assets are unmatched, but it requires deep partnership and investment. For personal mental w
These tools are incomparable: Recursion is a techbio platform for drug discovery with custom pricing and a massive wet lab, while Semrush One is a SaaS for SEO and AI search visibility with fixed ente
If you're a pharma company looking to accelerate early-stage drug discovery with a platform that combines massive phenomics data, automated wet labs, and AI modeling, Recursion is your choice. For lar
Explore each tool further
Browse these categories
One email a week — new tools, honest comparisons, no spam.
Last reviewed: July 30, 2026